Clas-goran Af Bjorkesten

Helsinki, 00290, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Gastrointestinal bacterial infections precede disease activation and treatment intensification in patients with inflammatory bowel disease.

Gastrointestinal bacterial infections precede disease activation and treatment intensification in patients with inflammatory bowel disease.

Journal: Therapeutic advances in gastroenterology

Published: March 18, 2025

Ustekinumab for ulcerative colitis: a nationwide real-life observational cohort study.

Ustekinumab for ulcerative colitis: a nationwide real-life observational cohort study.

Journal: European journal of gastroenterology & hepatology

Published: February 19, 2025

Correlation of a clinical activity index in comparison to frequently measured laboratory values in inflammatory bowel disease.

Correlation of a clinical activity index in comparison to frequently measured laboratory values in inflammatory bowel disease.

Journal: International journal of colorectal disease

Published: February 03, 2025

Higher disease activity of inflammatory bowel disease predisposes to Clostridioides difficile infection.

Higher disease activity of inflammatory bowel disease predisposes to Clostridioides difficile infection.

Journal: Therapeutic advances in gastroenterology

Published: July 11, 2024

Real-life experiences of switching from intravenous to subcutaneous vedolizumab maintenance therapy in patients with inflammatory bowel disease.

Real-life experiences of switching from intravenous to subcutaneous vedolizumab maintenance therapy in patients with inflammatory bowel disease.

Journal: European journal of gastroenterology & hepatology

Published: July 08, 2024

Tofacitinib real-world experience in ulcerative colitis in Finland (FinTofUC): a retrospective non-interventional multicenter patient chart data study.

Tofacitinib real-world experience in ulcerative colitis in Finland (FinTofUC): a retrospective non-interventional multicenter patient chart data study.

Journal: Scandinavian journal of gastroenterology

Published: December 29, 2023

Real-life treatment persistence and treatment outcomes of Finnish patients with inflammatory bowel disease receiving vedolizumab as first-line biological treatment.

Real-life treatment persistence and treatment outcomes of Finnish patients with inflammatory bowel disease receiving vedolizumab as first-line biological treatment.

Journal: Heliyon

Published: October 17, 2023

A nationwide real-world study on dynamic ustekinumab dosing and concomitant medication use among Crohn's disease patients in Finland.

A nationwide real-world study on dynamic ustekinumab dosing and concomitant medication use among Crohn's disease patients in Finland.

Journal: Scandinavian journal of gastroenterology

Published: April 06, 2021

Objectively assessed disease activity and drug persistence during ustekinumab treatment in a nationwide real-world Crohn's disease cohort.

Objectively assessed disease activity and drug persistence during ustekinumab treatment in a nationwide real-world Crohn's disease cohort.

Journal: European journal of gastroenterology & hepatology

Published: September 02, 2020

Ustekinumab for Crohn's disease: a nationwide real-life cohort study from Finland (FINUSTE).

Ustekinumab for Crohn's disease: a nationwide real-life cohort study from Finland (FINUSTE).

Journal: Scandinavian journal of gastroenterology

Published: June 12, 2019

Mucosal healing at 3 months predicts long-term endoscopic remission in anti-TNF-treated luminal Crohn's disease.

Mucosal healing at 3 months predicts long-term endoscopic remission in anti-TNF-treated luminal Crohn's disease.

Journal: Scandinavian journal of gastroenterology

Published: March 13, 2013

Surrogate markers and clinical indices, alone or combined, as indicators for endoscopic remission in anti-TNF-treated luminal Crohn's disease.

Surrogate markers and clinical indices, alone or combined, as indicators for endoscopic remission in anti-TNF-treated luminal Crohn's disease.

Journal: Scandinavian journal of gastroenterology

Published: February 24, 2012

Showing 1-12 of 14

Last Updated: 09/26/2026